1:21-cv-01042 | Neurocrine Biosciences, Inc. v. Lupin Limited et al | Jul 16, 2021 |
1:21-cv-01043 | Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al | Jul 16, 2021 |
1:21-cv-01067 | Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al | Jul 23, 2021 |
3:21-cv-14447 | Neurocrine Biosciences, Inc. v. ZYDUS PHARMACEUTICALS (USA) INC. et al | Jul 30, 2021 |
1:21-cv-01118 | Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al | Jul 30, 2021 |
2:21-cv-14447 | NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al | Jul 30, 2021 |
1:21-cv-01148 | Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al | Aug 6, 2021 |
1:21-cv-01408 | Neurocrine Biosciences, Inc. v. Lupin Limited et al | Oct 1, 2021 |
1:21-cv-01464 | Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al | Oct 18, 2021 |
3:21-cv-19466 | NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al | Oct 29, 2021 |
1:21-cv-01553 | Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al | Oct 29, 2021 |
2:21-cv-19466 | NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al | Oct 29, 2021 |
1:22-cv-00092 | Neurocrine Biosciences, Inc. v. Teva Pharmaceuticals, Inc. et al | Jan 21, 2022 |
3:22-cv-01882 | NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al | Apr 1, 2022 |
1:22-cv-00439 | Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al | Apr 1, 2022 |
1:22-cv-01882 | NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al | Apr 1, 2022 |
1:22-cv-00639 | Neurocrine Biosciences, Inc. v. Lupin Limited et al | May 13, 2022 |
1:22-cv-01061 | Neurocrine Biosciences, Inc. v. Lupin Limited et al | Aug 11, 2022 |
1:22-cv-01124 | Neurocrine Biosciences, Inc. v. Sandoz Inc. et al | Aug 26, 2022 |
3:22-cv-05830 | NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al | Sep 30, 2022 |
1:22-cv-01291 | Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al | Sep 30, 2022 |